Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.

Abstract

BACKGROUND:

Alterations in DNA methylation occur during the pathogenesis of human tumors. In this study, we investigated the influence of DNA methyltransferase 3b (DNMT3b) on fragile histidine trial (FHIT) expression and on DNA methylation of the FHIT promoter region in the hepatoma cell line SMMC-7721.

METHODS:

DNMT3b siRNA was used to down-regulate DNMT3b expression. DNMT3b and FHIT proteins were determined by Western blotting. Methylation-specific PCR was used to analyze the methylation status of the FHIT gene.

RESULTS:

After DNMT3b siRNA transfection, the expression of DNMT3b was inhibited in SMMC-7721 cells, and the expression of FHIT was significantly higher than that in the control group. There was no significant difference in methylation status between the DNMT3b siRNA transfected cells and control cells.

CONCLUSION:

DNMT3b may play an important role in regulation of FHIT expression in hepatoma SMMC-7721 cells, but not through methylation of the FHIT promoter.

• Authors: Jia-Xiang Wang, Yong-Gan Zhang, Long-Shuan Zhao
• Journal: Hepatobiliary & pancreatic diseases international : HBPD INT (Hepatobiliary Pancreat Dis Int) Vol. 8 Issue 3 Pg. 273-7 (Jun 2009) ISSN: 1499-3872 [Print] Singapore
• PMID: 19502167 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Neoplasm Proteins
• RNA, Small Interfering
• fragile histidine triad protein
• DNA (Cytosine-5-)-Methyltransferases
• DNA methyltransferase 3B
• Acid Anhydride Hydrolases

Topics

• Acid Anhydride Hydrolases (genetics, metabolism)
• Blotting, Western
• Carcinoma, Hepatocellular (genetics, metabolism, physiopathology)
• Cell Line, Tumor
• Cell Survival (drug effects)
• DNA (Cytosine-5-)-Methyltransferases (genetics, metabolism)
• DNA Methylation
• Down-Regulation
• Gene Silencing
• Humans
• Liver Neoplasms (genetics, metabolism, physiopathology)
• Neoplasm Proteins (genetics, metabolism)
• Polymerase Chain Reaction (methods)
• Promoter Regions, Genetic
• RNA, Small Interfering (pharmacology)
• Transfection